Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CYTOGEN LABS, INC

NPI: 1851877989 · COSTA MESA, CA 92627 · Clinical Medical Laboratory · NPI assigned 07/11/2018

$91.84
Total Medicaid Paid
252
Total Claims
230
Beneficiaries
5
Codes Billed
2020-10
First Month
2021-03
Last Month

Provider Details

Authorized OfficialKUEMERLE, IAN (CEO)
NPI Enumeration Date07/11/2018

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 29 $5.13
2021 223 $86.71

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 111 100 $54.84
G0659 Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes 95 84 $37.00
87641 17 17 $0.00
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 12 12 $0.00
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 17 17 $0.00